Motley Fool  Jul 25  Comment 
Whether you have a short, medium, or long-term time horizon, there's something to watch when this cloud company reports
Cloud Computing  Jun 23  Comment 
Companies, and entire industries, today face a choice between radical change—often involving the reinvention of a business model—and imminent obsolescence. Yet, despite the life-or-death stakes, only 50% of executives say...
Benzinga  Jun 18  Comment 
Medidata Solutions (NASDAQ: MDSO) gained more than three percent in Wednesday afternoon trading after investor Stephen Weiss said he had acquired shares in the software company. Medidata, which makes clinical data management systems, is "the...
TheStreet.com  Jun 18  Comment 
NEW YORK (TheStreet) -- Good day, traders! Today's top picks are DryShips , Medidata Solutions  and Twitter . 1. First, let's look at DryShips, the ocean transportation services for dry bulk and petroleum cargos as well as offshore...
Benzinga  Jun 17  Comment 
In a report published Tuesday, Stifel analyst Steve Rubis initiated coverage on Medidata Solutions (NASDAQ: MDSO) with a Buy rating and $47.00 price target. In the report, Stifel noted, “We are initiating coverage of Medidata Solutions with a...
Cloud Computing  May 7  Comment 
Medidata (NASDAQ : MDSO), le principal fournisseur mondial de solutions basées sur le «cloud» destinées à la recherche clinique dans le domaine des sciences de la vie, a annoncé aujourd’hui que Sanofi, l’une...
Cloud Computing  Apr 23  Comment 
Medidata (NASDAQ : MDSO), le leader mondial dans les solutions basées sur le Cloud pour la recherche clinique dans le secteur des sciences de la vie, a annoncé aujourd'hui ses résultats financiers pour le premier trimestre...
Cloud Computing  Apr 23  Comment 
Medidata (NASDAQ:MDSO), der führende weltweite Anbieter von cloudbasierten Lösungen für die klinische Forschung in den Biowissenschaften, legte heute seine Finanzergebnisse für das erste Quartal 2014 vor. read more
StreetInsider.com  Apr 23  Comment 
UPGRADES B. Riley upgrades Medidata Solutions (Nasdaq: MDSO) from Neutral to Buy with a price target of $49. SunPower (Nasdaq: SPWR) upgraded by two today: Deutsche Bank from Hold to Buy while moving its price target from $33 up to $38. Click...
TheStreet.com  Apr 23  Comment 
NEW YORK (TheStreet) -- Medidata Solutions  has had its price target decreased to $50 from $72.50, Jefferies said Wednesday. The firm said though first-quarter results were disappointing analysts are reiterating a "buy." Must Read: Warren...

Medidata Solutions (NASDAQ:MDSO) sells a software platform called Medidata Rave that helps biotech and pharmaceutical companies enhance the efficiency of their clinical development processes.[1] It achieves this by integrating electronic data capture (EDC) with a clinical data management system (CDMS) in a single product.
Medidata Rave is a comprehensive platform that replaces traditional paper-based methods of capturing and managing clinical data.
Medidata Rave is a comprehensive platform that replaces traditional paper-based methods of capturing and managing clinical data.
The company also sells a protocol authoring tool (Medidata Designer), a grant management system (Medidata Grant Manager) and a CRO contracting platform (Medidata CRO Contractor). In 2007, 2008 and the first quarter of 2009, the company's top five customers by revenue were Johnson & Johnson, AstraZeneca, Amgen, Astellas Pharma and Takeda Pharmaceutical.[1]

Medidata's initial public offering (IPO) of stock is scheduled for 18 June 2009. It plans to sell 6.3 million shares at between $11 and $12 per share. In 2008, the company had $106 million in total revenues, up 67.9% from $63.0 million in 2007. However, it still made a net loss of $18.3 million, down 22.8% from the $23.7 million net loss made in 2007.[2] In the same year, 69% of revenues came from customers in the United States, 21% from Europe and 10% from Asia (including Australia). In the first quarter of 2009, the company had $33.6 million in total revenues, up 60.2% from $21.0 million in the same quarter of the 2008.[2] It also had $1.7 million in net income, up 120% from the $8.6 million net loss made in 2007. Existing investors in the company include Insight Venture Partners (33.9%), chief executive officer and chairman Tarek Sherif (9.0%), president and director Glen M. de Vries (9.0%) and Milestone Venture Partners (7.6%).


  1. 1.0 1.1 Business, 2009 MDSO S-1/A
  2. 2.0 2.1 Selected Consolidated Financial Information, 2009 MDSO S-1/A
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki